Steven Patierno, PhD

Professor of Medicine
Professor of Pharmacology and Cancer Biology
Professor in Family Medicine and Community Health
Core Faculty Member, Duke-Margolis Center for Health Policy
Member of the Duke Cancer Institute
Campus mail 10 Bryan Searle Drive, Seeley Mudd Building, Suite 413, Durham, NC 27710
Phone (919) 613-5093
Email address steven.patierno@duke.edu

Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research.   Patierno is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.

Education and Training

  • Postdoctoral Training, Norris Comprehensive Cancer, University of Southern California, 1986 - 1988
  • Ph.D., University of Texas Medical School, Houston, 1985
  • B.S., University of Connecticut, 1981

Publications

Wang, Bi-Dar, Ramez Andrawis, Dana Rice, Faisal Ahmed, Harold Frazier, Thomas Jarrett, Steven Patierno, and Norman Lee. “977 GENOMIC STUDY OF PROSTATE CANCER DISPARITIES BETWEEN AFRICAN AMERICAN AND CAUCASIAN AMERICAN POPULATIONS.” In Journal of Urology, Vol. 189. Ovid Technologies (Wolters Kluwer Health), 2013. https://doi.org/10.1016/j.juro.2013.02.559.

Full Text

Bensink, M. E., S. D. Ramsey, T. Battaglia, K. Fiscella, T. C. Hurd, J. M. Mckoy, S. R. Patierno, et al. “Costs and outcomes evaluation of patient navigation after abnormal cancer screening: Evidence From the Patient Navigation Research Program.” Cancer, 2013.

Scholars@Duke

Simon, M. A., A. K. Patterson, B. C. Risendal, and S. Patierno. “Erratum: Survivorship navigation outcome measures: A report from the ACS Patient Navigation Working Group on Survivorship Navigation (Cancer (2011) 117 (3575-84)).” Cancer 118, no. 21 (November 1, 2012): 5450. https://doi.org/10.1002/cncr.27546.

Full Text

Hoffman, Heather J., Nancy L. LaVerda, Heather A. Young, Paul H. Levine, Lisa M. Alexander, Rachel Brem, Larisa Caicedo, et al. “Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia.” Cancer Epidemiol Biomarkers Prev 21, no. 10 (October 2012): 1655–63. https://doi.org/10.1158/1055-9965.EPI-12-0479.

PMID
23045540
Full Text

Jean-Pierre, Pascal, Kevin Fiscella, Paul C. Winters, Electra Paskett, Kristen Wells, Tracy Battaglia, and Tracy Patient Navigation Research Program Group. “Psychometric validation and reliability analysis of a Spanish version of the patient satisfaction with cancer-related care measure: a patient navigation research program study.” Support Care Cancer 20, no. 9 (September 2012): 1949–56. https://doi.org/10.1007/s00520-011-1297-3.

PMID
22038482
Full Text

Kost, Gina Chun, Steven R. Patierno, Sandra S. Wise, Amie L. Holmes, John Pierce Wise, and Susan Ceryak. “Protein tyrosine phosphatase (PTP) inhibition enhances chromosomal stability after genotoxic stress: decreased chromosomal instability (CIN) at the expense of enhanced genomic instability (GIN)?” Mutat Res 735, no. 1–2 (July 1, 2012): 51–55. https://doi.org/10.1016/j.mrfmmm.2012.05.001.

PMID
22583656
Full Text

Roetzheim, Richard G., Karen M. Freund, Don K. Corle, David M. Murray, Frederick R. Snyder, Andrea C. Kronman, Pascal Jean-Pierre, et al. “Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program.” Clin Trials 9, no. 2 (April 2012): 176–87. https://doi.org/10.1177/1740774511433284.

PMID
22273587
Full Text

Schneider, Brent C., Stephanie L. Constant, Steven R. Patierno, Rosalyn A. Jurjus, and Susan M. Ceryak. “Exposure to particulate hexavalent chromium exacerbates allergic asthma pathology.” Toxicol Appl Pharmacol 259, no. 1 (February 15, 2012): 38–44. https://doi.org/10.1016/j.taap.2011.12.001.

PMID
22178736
Full Text

Norris, L., J. Bretsch, S. LaMonte, M. Pratt-Chapman, R. Cowens-Alvarado, K. Sharpe, and S. Patierno. “Addressing Gaps in the US Healthcare System to Improve Cancer Survivor Quality of Life.” Psycho Oncology 21 (February 2012): 1–2.

Scholars@Duke

Cannady, R. S., A. Willis, D. Wiatrek, K. Stein, R. Cowens-Alvarado, M. Pratt-Chapman, S. Patierno, and K. Sharpe. “Understanding Cancer Survivors' Needs to Improve Quality of Life.” Psycho Oncology 21 (February 2012): 1–1.

Scholars@Duke

Pages